文献速递头颈神经CTMR

HPV相关口咽鳞癌颈部淋巴结转移预测模型

Prediction model for cervical lymph node metastasis in human papillomavirus-related oropharyngeal squamous cell carcinomas.
PubMed 文献 · Eur Radiol · 2021-03-29

本研究基于两家三级转诊医院的历史队列,利用治疗前CT或MR的临床与影像表现构建并验证预测HPV阳性口咽鳞癌淋巴结转移的7分风险评分系统。训练集455枚淋巴结(82例),测试集150枚淋巴结(42例),以病理为参考标准。评分系统在训练集C-statistic 0.952(95%CI 0.931-0.972),测试集C-statistic 0.968(95%CI 0.936-0.999),校准良好。

要点

  • 7分风险评分基于中央坏死、侵犯邻近平面、淋巴结分区和最大轴径预测转移。
  • 训练集C-statistic 0.952(95%CI 0.931-0.972),测试集0.968(95%CI 0.936-0.999)。
  • 校准能力训练集p=0.723,测试集p=0.253,判别与校准均良好。

关键影像表现/征象

  • 评分系统纳入中央坏死、侵犯邻近平面、淋巴结分区和淋巴结最大轴径四个变量。
  • 构建为7分风险评分系统。

诊断标准与关键数值

  • 训练集C-statistic 0.952(95%CI 0.931-0.972),测试集C-statistic 0.968(95%CI 0.936-0.999)。
  • 校准能力训练集p=0.723,测试集p=0.253。

临床应用与阅片要点

  • 基于治疗前CT或MR评估中央坏死、侵犯邻近平面、淋巴结分区和最大轴径,可用于HPV+口咽鳞癌淋巴结转移风险分层。
  • 原文未报告具体评分阈值或分级标准。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To develop and validate a risk scoring system based on clinical and imaging findings to predict lymph node metastasis from HPV-related oropharyngeal squamous cell carcinomas.

METHODS: This study population who had undergone neck dissections or lymph node biopsies in patients with HPV+ OPSCC was obtained from a historical cohort from two tertiary referral hospitals. The training set from one hospital included 455 lymph nodes from 82 patients, and the test set from the other hospital included 150 lymph nodes from 42 patients. The baseline clinical and imaging findings on pretreatment CT or MR were investigated and the reference standards were the histopathologic results. A risk scoring system was constructed based on logistic regression and validated both internally and externally.

RESULTS: A 7-point risk scoring system was developed based on the following variables: central necrosis, infiltration of adjacent planes, lymph node level, and the maximal axial diameter of the lymph node. This risk scoring system showed good discriminative ability for metastasis in the training set (C-statistic 0.952; 95% CI, 0.931-0.972) and test set (C-statistic 0.968, 95% CI, 0.936-0.999) and good calibration ability in the training set (p = 0.723) and test set (p = 0.253).

CONCLUSIONS: We developed and validated a reliable risk scoring system that predicts lymph node metastasis from HPV+ OPSCCs based on the clinical data and pretreatment imaging findings. We expect this risk scoring system to be a useful guide for better decision-making in practice.

KEY POINTS: • It is important to diagnose lymph node metastasis from HPV+ OPSCC for treatment planning; however, there has been little research on that. • We developed and externally validated a new scoring system for stratifying the risk of lymph node metastasis from HPV+ OPSCC based on clinical and imaging data. • A predictive model combining both clinical and imaging data showed high diagnostic accuracy and efficiency for lymph node metastasis from HPV+ OPSCC.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Joo L, Bae YJ, Choi YJ, et al. Prediction model for cervical lymph node metastasis in human papillomavirus-related oropharyngeal squamous cell carcinomas. Eur Radiol. 2021. PMID: 33779817. doi:10.1007/s00330-021-07766-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。